Q1 2025 Holdings
Filed 2025-05-15 | 12 holdings | $413.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $223.8M | 10,935,310 | 54.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $57.1M | 5,462,846 | 13.8% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $43.2M | 9,632,561 | 10.4% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $38.1M | 3,909,696 | 9.2% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $29.3M | 3,452,330 | 7.1% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $20.4M | 3,822,537 | 4.9% |
| Engene Holdings Inc(ENGNW) | W EXP 10/31/2028 | 29286M113 | $1.7M | 2,878,148 | 0.4% |